-
101
Economic Evaluation of Robotic-assisted Radical Prostatectomy: A Systematic Review and Meta-analysis
Published 2025-02-01Get full text
Article -
102
Scoping review of costs of implementation strategies in community, public health and healthcare settings
Published 2022-06-01Get full text
Article -
103
-
104
Film Cooling from a Single Row of Compound Angle Holes at High Blowing Ratios
Published 1996-01-01Get full text
Article -
105
A Variational Calculation of Diffusive Flux in a Mixed Boundary Value Problem
Published 2023-06-01Get full text
Article -
106
-
107
Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma
Published 2019-01-01Get full text
Article -
108
-
109
Reverse epidemiology of obesity paradox: Fact or fiction?
Published 2024-11-01Get full text
Article -
110
-
111
Aura phenomenon: a proposal for an etiology-based clinical classification
Published 2025-01-01Get full text
Article -
112
Complex Scapular Winging following Total Shoulder Arthroplasty in a Patient with Ehlers-Danlos Syndrome
Published 2015-01-01Get full text
Article -
113
-
114
-
115
-
116
-
117
-
118
The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
Published 2011-01-01Get full text
Article -
119
-
120
Update on Surgical Techniques Best Practices to Optimize Outcomes Following Gel Stent Implantation
Published 2025-01-01“…Vanessa Vera,1 Arsham Sheybani,2 Joseph F Panarelli,3 Davinder S Grover,4 James Lee,5 Earl Randy Craven,2 Thomas W Samuelson,6 Iqbal Ike K Ahmed7 1Allergan, an AbbVie company, Irvine, CA, USA; 2Washington University School of Medicine, St Louis, MO, USA; 3Department of Ophthalmology, New York University Langone Health, New York, NY, USA; 4Glaucoma Associates of Texas, Dallas, TX, USA; 5Colorado Eye Institute, Colorado Springs, CO, USA; 6Minnesota Eye Consultants, University of Minnesota, Minneapolis, MN, USA; 7John Moran Eye Center, University of Utah, Salt Lake City, UT, USACorrespondence: James Lee, Colorado Eye Institute, Colorado Springs, CO, 80924, USA, Email jlee@eyescolorado.comAbstract: The XEN® 45 Glaucoma Treatment System (gel stent; Allergan, an AbbVie company, Irvine, CA, USA) is a minimally invasive bleb-forming surgical device that was originally approved to lower intraocular pressure by diverting the aqueous humor from the anterior chamber to the subconjunctival space (like trabeculectomy) following ab-interno placement. …”
Get full text
Article